Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Recent & Breaking News (TSX:VRX)

Valeant Announces Pricing Of Private Offering Of Add-On Secured Notes

PR Newswire November 14, 2017

Ortho Dermatologics Announces Aspire Higher Scholarship Honorees

PR Newswire November 14, 2017

Valeant Announces Launch of Private Offering of Add-On Secured Notes

PR Newswire November 13, 2017

Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisition Fund I, L.P.

PR Newswire November 10, 2017

Valeant To Participate At The Stifel 2017 Healthcare Conference

PR Newswire November 8, 2017

EyeGate Completes Enrollment in Phase 2b Clinical Trial of EGP-437 for Cataract Surgery

GlobeNewswire November 8, 2017

Valeant Announces Third-Quarter 2017 Results

PR Newswire November 7, 2017

Valeant Pharmaceuticals International Inc to Host Earnings Call

Accesswire November 7, 2017

Valeant Agrees To Sell Sprout Pharmaceuticals Subsidiary To Former Shareholders Of Sprout Pharmaceuticals

PR Newswire November 6, 2017

Bausch + Lomb And Nicox Announce FDA Approval Of VYZULTA™ (latanoprostene Bunod Ophthalmic Solution), 0.024%

PR Newswire November 2, 2017

Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-118, Novel Plaque Psoriasis Treatment

PR Newswire November 2, 2017

Valeant Will Reduce Debt By Additional $125 Million

PR Newswire October 31, 2017

Pharming Group Reports Financial Results for the First Nine Months of 2017

PR Newswire Europe Non Regulatory October 26, 2017

Thinking about buying stock in Delta Airlines, The Goldman Sachs Group, MOMO Inc., Micron or Valeant Pharmaceuticals?

PR Newswire October 17, 2017

Valeant And One Of Its Subsidiaries Announce Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes

PR Newswire October 16, 2017

Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ™ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile

PR Newswire October 12, 2017

VRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors

PR Newswire October 5, 2017

Stock Performance Review on Drug Delivery Industry -- Adamis Pharma, Alkermes, PetMed Express, and Valeant Pharma

PR Newswire October 5, 2017

Watch These 8 Huge Put Purchases In Thursday Trade

Benzinga.com  October 5, 2017

Solta Medical Receives FDA 510(k) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing Technology

PR Newswire October 4, 2017